Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.

The performances of the ImmuView Streptococcus pneumoniae (Sp) and Legionella pneumophila (Lp) urinary antigen test were compared to that of the BinaxNOW Sp and Lp assays, using frozen urine from 166 patients with Legionnaires' disease (LD) and 59 patients with pneumococcal pneumonia. Thirty Sp...

Full description

Bibliographic Details
Main Authors: Paul H Edelstein, Charlotte Sværke Jørgensen, Leslie A Wolf
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0238479
_version_ 1819016351040143360
author Paul H Edelstein
Charlotte Sværke Jørgensen
Leslie A Wolf
author_facet Paul H Edelstein
Charlotte Sværke Jørgensen
Leslie A Wolf
author_sort Paul H Edelstein
collection DOAJ
description The performances of the ImmuView Streptococcus pneumoniae (Sp) and Legionella pneumophila (Lp) urinary antigen test were compared to that of the BinaxNOW Sp and Lp assays, using frozen urine from 166 patients with Legionnaires' disease (LD) and 59 patients with pneumococcal pneumonia. Thirty Sp-positive or contrived cerebrospinal fluids (CSF) were also tested. Test specimens were collected and tested at different sites, with each site testing unique specimens by technologists blinded to expected results. No significant differences in test concordances were detected for the ImmuView and BinaxNOW assays for the Sp or Lp targets for urine from patients with pneumococcal pneumonia or LD when performance from both sites were combined. At one of two test sites the ImmuView Lp assay was more sensitive than the BinaxNOW assay, with no correlation between test performance and Lp serogroup 1 monoclonal type. Urines from six of seven patients with LD caused by Legionella spp. bacteria other than Lp serogroup 1 were negative in both assays. Both tests had equivalent performance for Sp-positive CSF. The clinical sensitivities for pneumococcal pneumonia were 88.1 and 94.4% for the ImmuView and Binax assays, and 87.6 and 84.2% for the Lp assays, respectively. Test specificities for pneumococcal pneumonia were 96.2 and 97.0% for the ImmuView and Binax assays, and 99.6 and 99.1% for the Lp assays. Both assays were highly specific for Sp in pediatric urines from children with nasopharyngeal colonization by the bacterium. ImmuView and BinaxNOW assay performance was equivalent in these studies.
first_indexed 2024-12-21T02:46:15Z
format Article
id doaj.art-a2d4bfbbfff5470a9ab03e256bfd1156
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T02:46:15Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a2d4bfbbfff5470a9ab03e256bfd11562022-12-21T19:18:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01158e023847910.1371/journal.pone.0238479Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.Paul H EdelsteinCharlotte Sværke JørgensenLeslie A WolfThe performances of the ImmuView Streptococcus pneumoniae (Sp) and Legionella pneumophila (Lp) urinary antigen test were compared to that of the BinaxNOW Sp and Lp assays, using frozen urine from 166 patients with Legionnaires' disease (LD) and 59 patients with pneumococcal pneumonia. Thirty Sp-positive or contrived cerebrospinal fluids (CSF) were also tested. Test specimens were collected and tested at different sites, with each site testing unique specimens by technologists blinded to expected results. No significant differences in test concordances were detected for the ImmuView and BinaxNOW assays for the Sp or Lp targets for urine from patients with pneumococcal pneumonia or LD when performance from both sites were combined. At one of two test sites the ImmuView Lp assay was more sensitive than the BinaxNOW assay, with no correlation between test performance and Lp serogroup 1 monoclonal type. Urines from six of seven patients with LD caused by Legionella spp. bacteria other than Lp serogroup 1 were negative in both assays. Both tests had equivalent performance for Sp-positive CSF. The clinical sensitivities for pneumococcal pneumonia were 88.1 and 94.4% for the ImmuView and Binax assays, and 87.6 and 84.2% for the Lp assays, respectively. Test specificities for pneumococcal pneumonia were 96.2 and 97.0% for the ImmuView and Binax assays, and 99.6 and 99.1% for the Lp assays. Both assays were highly specific for Sp in pediatric urines from children with nasopharyngeal colonization by the bacterium. ImmuView and BinaxNOW assay performance was equivalent in these studies.https://doi.org/10.1371/journal.pone.0238479
spellingShingle Paul H Edelstein
Charlotte Sværke Jørgensen
Leslie A Wolf
Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.
PLoS ONE
title Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.
title_full Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.
title_fullStr Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.
title_full_unstemmed Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.
title_short Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires' disease or pneumococcal pneumonia and meningitis.
title_sort performance of the immuview and binaxnow assays for the detection of urine and cerebrospinal fluid streptococcus pneumoniae and legionella pneumophila serogroup 1 antigen in patients with legionnaires disease or pneumococcal pneumonia and meningitis
url https://doi.org/10.1371/journal.pone.0238479
work_keys_str_mv AT paulhedelstein performanceoftheimmuviewandbinaxnowassaysforthedetectionofurineandcerebrospinalfluidstreptococcuspneumoniaeandlegionellapneumophilaserogroup1antigeninpatientswithlegionnairesdiseaseorpneumococcalpneumoniaandmeningitis
AT charlottesværkejørgensen performanceoftheimmuviewandbinaxnowassaysforthedetectionofurineandcerebrospinalfluidstreptococcuspneumoniaeandlegionellapneumophilaserogroup1antigeninpatientswithlegionnairesdiseaseorpneumococcalpneumoniaandmeningitis
AT leslieawolf performanceoftheimmuviewandbinaxnowassaysforthedetectionofurineandcerebrospinalfluidstreptococcuspneumoniaeandlegionellapneumophilaserogroup1antigeninpatientswithlegionnairesdiseaseorpneumococcalpneumoniaandmeningitis